Blood Glucose Test Strips Market: Wicking technology segment is projected to dominate the market
Global Blood Glucose Test Strips Market – Snapshot
Blood glucose test strips are used to measure the glucose level in the blood. In terms of revenue, the global blood glucose test strips market was valued at US$ 8,000 Mn in 2017 and is anticipated to reach around US$ 9,700 Mn by 2026, expanding at a CAGR of above 2.0% from 2018 to 2026. Rise in prevalence of diabetes and high awareness for continuous glucose monitoring in order to control diabetes are likely to drive the global blood glucose test strips market from 2018 to 2026.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2424
Prevalence of diabetes is expected to increase exponentially, worldwide, due to change in lifestyle and various factors such as malnutrition and genetic mutations. According to various government and private organizations operating in the diabetes industry, diabetes is considered a major fatal disease. Large number of global manufacturers are focusing on the development and manufacture of novel diabetes products in order to meet the medical need of patients with the favorable support of the government. For instance, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for DarioHealth Corp., the manufacturer of Dario blood glucose monitoring system, including its components such as meter, test strips, and apps on the Apple iOS 6.1 platform and higher. Such key developments are likely to augment the global blood glucose test strips market in the near future. However, incidence of product recall due to device inefficiency such as false glucose reading or intense competition leading to pricing pressures are some factors that are likely to restrain the global blood glucose test strips market during the forecast period.
Request for Analysis of COVID-19 Impact on Blood Glucose Test Strips Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2424
The global blood glucose test market can be segmented based on technology, distribution channel, and region. In terms of technology, the wicking technology segment is projected to dominate the market; however, it is expected to maintain its dominance during the forecast period due to increase in usage among patients to achieve accurate results during testing. The channel technology segment is likely to lose market share during the forecast period. Increase in demand for accurate result in short time and less focus of major players on the development of strips through channel technology are key factors fueling the segment. Based on distribution channel, the retail pharmacy segment led the market, in terms of revenue, in 2017, while the hospital pharmacy segment is projected to lose market share during the forecast period due to rise in preference for self-care testing among patients for diabetes monitoring.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2424
In terms of region, North America held a major share of the global blood glucose test strips market in 2017. However, it is expected to lose market share during the forecast period due to rise in usage of generic test strips. Europe followed North America in terms of share of the global market. In terms of revenue, the market in Asia Pacific is projected to expand at a rapid pace during the forecast period. Rise in prevalence of diabetes and awareness about the treatment and usage of different devices to treat diabetes in countries such as Brazil, Saudi Arabia, and South Africa are likely to boost the market in Latin America and Middle East & Africa.
Buy Blood Glucose Test Strips Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=2424<ype=S
Key companies operating in the global blood glucose test strips market, which are profiled in the report, include Abbott Laboratories, AgaMatrix, Inc., (Ascensia Diabetes Care Holdings AG) PHC Holdings Corporation, F. Hoffmann-La Roche Ltd., LifeScan, Inc. (Johnson & Johnson), Sanofi, Trividia Health, Inc., and B. Braun Holding GmbH & Co. KG. These players are adopting organic and in-organic growth strategies to expand their product offerings, strengthen their geographical reach, increase customer base, and gain market share. For instance, in June 2017, F. Hoffmann-La Roche Ltd. acquired Austria-based company mySugr GmbH. This acquisition helped F. Hoffmann-La Roche Ltd to access its mobile diabetes platform apps and services, which include diabetes coaching, therapy management, and unlimited test strips.
Top of Form
Top of Form
Read more information here:
https://www.transparencymarketresearch.com/blood-glucose-test-strips.html
Top of Form
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453